课题基金 / 基金详情

Understanding cell-type vulnerability and oxidative stress pathology in Parkinson's Disease using isogenic human dopaminergic neurons

Understanding cell-type vulnerability and oxidative stress pathology in Parkinson's Disease using isogenic human dopaminergic neurons
使用同基因人类多巴胺能神经元了解帕金森病的细胞类型脆弱性和氧化应激病理学
批准号:
10458745
负责人:
Joel William Blanchard
金额:
$39.83万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-08-31
关键词:
AffectAmericanAutopsyBiological ModelsBrainCRISPR-mediated transcriptional activationCandidate Disease GeneCaregiversCell DeathCell LineCell modelCell physiologyCellsCessation of lifeClustered Regularly Interspaced Short Palindromic RepeatsConsequentialismDNA DamageDataData SetDiagnosisDiseaseDisease modelDopamineEnvironmentFlow CytometryFluorescent DyesFunctional disorderGene ExpressionGenesGeneticGenotypeGoalsHumanHypothalamic structureImageIndividualInheritedKnock-inKnowledgeLeadLentivirus VectorLipidsMendelian disorderMetabolismMidbrain structureMissionMitochondriaMitochondrial ProteinsModelingMolecularMutagenesisMutationNerve DegenerationNeuronsOrganoidsOutcomeOxidative StressOxidative Stress PathwayPARK7 genePARK9 geneParkinson DiseaseParkinsonian DisordersPathologicPathologyPathway AnalysisPathway interactionsPatientsPatternPharmacologyPhenotypePopulationPopulation AnalysisPreventionPrevention strategyProsencephalonProteinsProteomicsPublic HealthReactive Oxygen SpeciesReporterResearchResearch ProposalsRiskScientistSignal TransductionSignaling MoleculeSourceSystemTechnologyTestingTherapeuticTimeTissuesTyrosine 3-MonooxygenaseUnited States National Institutes of Healthbiological adaptation to stresscandidate validationcell typedisease-causing mutationdisorder riskdopaminergic neuronearly onsetgene networkhuman pluripotent stem cellimprovedinnovationinsightknock-downloss of functionmolecular subtypesmotor impairmentmultiple omicsnew therapeutic targetnovelnovel strategiespatient stratificationprotein aggregationresponsesingle-cell RNA sequencingtooltraffickingtranscriptomics

项目摘要

项目成果

Joel William Blanchard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
About one million Americans live with Parkinson's Disease (PD) which is characterized by progressive loss of subpopulations of nigral midbrain dopaminergic neurons (DNs), leading to motor impairment and other debilitating conditions. Familial PD genes show broad expression in the brain and neurodegeneration in PD can be widespread; however, it is unclear why nigral DNs show such exquisite vulnerability compared to other cell types, including other DN populations. Post-mortem studies suggest that oxidative stress (OS) contributes to familial and sporadic PD. Reactive oxygen species (ROS) are important signaling molecules but high levels of intracellular ROS will damage DNA, lipids and proteins. High energy needs and dopamine metabolism may explain increased ROS, OS and the unique vulnerability of nigral DNs but human-relevant model systems are required to rigorously test this hypothesis. There is an urgent need to develop experimental systems to better understand nigral DN vulnerability, identify novel disease-relevant signaling mechanisms, and improve molecular subtyping and patient stratification. Our long-term goal is to understand the vulnerability of nigral DNs through the interplay of genetics, cell type specific functions that confer vulnerability and quantifiable phenotypes to identify new therapeutic targets. In support of this goal, we have developed knock-in human pluripotent stem cell (hPSC) reporter lines to identify and isolate tyrosine hydroxylase (TH)-positive DNs from large-scale organoid spin cultures. Using CRISPR mutagenesis we created isogenic loss-of-function models of early-onset autosomal recessive PD (PARKIN-/-, DJ1-/- and ATP13A2-/-) in TH-reporter cell lines. We detected dysregulation of mitochondrial proteins, significantly increased OS and cell death in isogenic PD cell lines in midbrain DNs, but not in isogenic WT-control DNs. To understand nigral DN vulnerability we propose to use our isogenic reporter PD model and single-cell RNA sequencing approaches of human midbrain, hypothalamic and forebrain DNs to identify populations of cells that show increased vulnerability to OS and cell death and identify differentially affected DN populations. Expression and network analysis will identify cellular functions that confer vulnerability. We have developed genetic tools to distinguish primary dysregulation from emerging phenotypes to further the mechanistic understanding of genotype-phenotype interactions. Using innovative CRISPR-activation and inhibition technologies we will test identified candidate genes for their potential to ameliorate OS phenotypes and cell death in our PD model. Our model is conceptually and technically innovative and will illuminate common and unique pathways that confer vulnerability or protection in nigral DNs and propose novel strategies for prevention and treatment to improve the lives of patients and their caregivers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding cell-type vulnerability and oxidative stress pathology in Parkinson's Disease using isogenic human dopaminergic neurons
Understanding Cell-type Vulnerability and Oxidative Stress Pathology in Parkinson's Disease Using Isogenic Human Dopaminergic Neurons
Understanding Cell-type Vulnerability and Oxidative Stress Pathology in Parkinson's Disease Using Isogenic Human Dopaminergic Neurons
Construction of an integrated immune - vascular brain - chip as a platform for the study, drug screening, and treatments of Alzheimer's disease
海外基金